Avisi Technologies is an ophthalmic medical device company focused on developing nanotechnology-enabled glaucoma solutions. Its flagship VisiPlate device is an investigational aqueous shunt designed to lower intraocular pressure in open-angle glaucoma, leveraging MEMS manufacturing and ultrathin metamaterial design to improve biocompatibility and outcomes. The company highlights cutting-edge microfabrication techniques and advanced materials, aiming to advance minimally invasive glaucoma treatment. Based in the United States, Avisi emphasizes clinical research and regulatory progress in the US and worldwide.
No recent news for this company.